Human Pathology
Volume 36, Issue 5 , Pages 494-504 , May 2005

Differential gene expression in anaplastic lymphoma kinase–positive and anaplastic lymphoma kinase–negative anaplastic large cell lymphomas

  • Mary Ann Thompson, MD, PhD

      Affiliations

    • Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • Corresponding Author InformationCorresponding author. Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232.
    • ,
  • Jennifer Stumph, MD

      Affiliations

    • Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • ,
  • Sarah E. Henrickson, BS

      Affiliations

    • Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    • ,
  • Andreas Rosenwald, MD

      Affiliations

    • Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    • Current affiliation: University of Wuerzburg, Wuerzburg, Germany.
    • ,
  • QiFu Wang, BS

      Affiliations

    • Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • ,
  • Sandy Olson, PhD

      Affiliations

    • Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • ,
  • Stephen J. Brandt, MD

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • ,
  • Jeremy Roberts, BS

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • ,
  • Xueqiong Zhang, MS

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • ,
  • Yu Shyr, PhD

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • ,
  • Marsha C. Kinney, MD

      Affiliations

    • Department of Pathology, University of Texas Health Sciences Center at San Antonio, San Antonio, TX 78229, USA

References 

  1. Morris S, Xue L, Zhigui M, et al. ALK+ CD30+ lymphomas: a distinct molecular genetic subtype of non–Hodgkin's lymphoma. Br J Haematol. 2001;113:275–295
  2. Morris S, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non–Hodgkin's lymphoma. Science. 1994;263:1281–1284
  3. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. 1998;91:2076–2084
  4. Chan WY, Liu QR, Borjigin J, et al. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry. 1989;28:1033–1039
  5. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997;89:1394–1404
  6. Bai R-Y, Dieter P, Peschel C, et al. Nucleophosmin–anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity. Mol Cell Biol. 1998;18:6951–6961
  7. Gu T-L, Tothova Z, Scheijen B, Griffin B, Gilliland DG, Sternberg DW. NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a. Blood. 2004;103:4622–4629
  8. Zhang Q, Raghunath PN, Xue L, et al. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase–positive T/null-cell lymphoma. J Immunol. 2002;168:466–474
  9. Kinney MC, Kadin M. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol. 1999;111:S56–S67
  10. DeCoteau JF, Butmarc JR, Kinney MC, et al. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood. 1996;87:3437–3441
  11. Li G, Salhany KE, Rook AH, et al. The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation. J Cutan Pathol. 1997;24:403–408
  12. Wang E, Miller LD, Ohnmacht GA, et al. High fidelity mRNA amplification for gene profiling. Nat Biotechnol. 2000;18:457–459
  13. Alizadeh AA, Eisen MB, Davis RE, et al. The Lymphochip: a specialized cDNA microarray for the genome-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol. 1999;64:71
  14. Everit BS. Cluster analysis. New York: Edward Arnold; 1993;
  15. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344:539–548
  16. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116–5121
  17. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998;95:14863–14868
  18. Midmer M, Haq R, Squire JA, et al. Identification of NKIAMRE, the human homologue to the mitogen-activated protein kinase–/cyclin-dependent kinase–related protein kinase NKIATRE, and its loss in leukemic blasts with chromosome arm 5q deletion. Cancer Res. 1999;59:4069–4074
  19. Miething C, Grundler R, Fend F, et al. The oncogenic fusion protein NPM-ALK induces 2 distinct malignant phenotypes in a murine retroviral transplantation model. Oncogene. 2003;22:4642–4647
  20. Nieborowska-Skorska M, Slupianek A, Xue L, et al. Role of signal transducer and activator of transcription 5 in nucleophosmin/anaplastic lymphoma kinase–mediated malignant transformation of lymphoid cells. Cancer Res. 2001;61:6517–6523
  21. Villalva C, Trempat P, Greenland C, et al. Isolation of differentially expressed genes in NPM-ALK–positive anaplastic large cell lymphoma. Br J Haematol. 2002;118:791–798
  22. Wellmann A, Thieblemont C, Pittaluga S, et al. Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large cell lymphomas. Blood. 2000;96:398–404
  23. Li S, Ross D, Kadin M, et al. Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol. 2001;158:1231–1237
  24. Fillmore G, Lin Z, Bohling S, et al. Gene expression profiling of cell lines derived from T-cell malignancies. FEBS Lett. 2002;522:183–188
  25. Ortega S, Malumbres M, Barbacid M. Cyclin D–dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta. 2002;1602:73–87
  26. Doglioni C, Chiarelli C, Macri E, et al. Cyclin D3 expression in normal, reactive, and neoplastic tissues. J Pathol. 1998;185:159–166
  27. Gong J, Bhatia U, Traganos F, et al. Expression of cyclins A, D2 and D3 in mitogen-stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multi-parameter flow cytometry. Leukemia. 1995;9:893–899
  28. Moller M, Nielsen O, Pedersen NT. Cyclin D3 expression in non–Hodgkin lymphoma. Am J Clin Pathol. 2001;115:404–412
  29. Sicinska E, Aifantis I, Le Dam L, et al. Requirements for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell. 2003;4:451–461
  30. Stepanova L, Finegold M, DeMayo F, et al. The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues. Mol Cell Biol. 2000;20:4462–4473
  31. Malstrom S, Tili E, Kappes D, et al. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. Proc Natl Acad Sci U S A. 2001;98:14967–14972
  32. Jiang K, Zhong B, Ritchey C, et al. Regulation of Akt-dependent cell survival by Syk and Rac. Blood. 2003;101:236–244
  33. Amin HM, McDonnell TJ, Ma Y, et al. Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene. 2004;1–9[online publication]
  34. Lae M, Ahmed I, Macon WR. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. Am J Clin Pathol. 2002;118:773–779
  35. Crockett DK, Zhaosheng L, Elenitoba-Johnson K, et al. Identification of NPM-ALK interacting proteins by tandem mass spectrometry. Oncogene. 2004;23:12617–12629

☆ This study was supported by the Vanderbilt University Medical Center Department of Pathology (Nashville, Tenn).

PII: S0046-8177(05)00128-0

doi: 10.1016/j.humpath.2005.03.004

Human Pathology
Volume 36, Issue 5 , Pages 494-504 , May 2005

Article Tools

* Image Usage & Resolution